Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry W Long

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|February 8, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Nature Cell Biology|August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancerLeslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Iscience|November 8, 2019
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast CancersSuriyan Ponnusamy, Sarah Asemota, Lee S Schwartzberg, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Cell Reports|November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancerBenedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Cancer Research|November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Matthew P Keany, Han Dong, et al.
Cancer Cell|July 19, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|February 8, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Nature Cell Biology|August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancerLeslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Iscience|November 8, 2019
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast CancersSuriyan Ponnusamy, Sarah Asemota, Lee S Schwartzberg, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Cell Reports|November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancerBenedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Cancer Research|November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Matthew P Keany, Han Dong, et al.
Cancer Cell|July 19, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Pageof 10